GSK plcGSKNYSE
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$3.57B
↓ 29% below average
Average (9y)
$5.04B
Historical baseline
Range
High:$6.75B
Low:$668.00M
CAGR
+20.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $3.57B | -42.9% |
| 2023 | $6.26B | -7.3% |
| 2022 | $6.75B | +27.5% |
| 2021 | $5.30B | -18.4% |
| 2020 | $6.50B | +10.9% |
| 2019 | $5.86B | -11.6% |
| 2018 | $6.63B | +40.5% |
| 2017 | $4.72B | +13.8% |
| 2016 | $4.14B | +520.5% |
| 2015 | $668.00M | - |